# Data analysis for drug repositioning 

 A comprehensive data mining and analysis effort has been done to present these lists of existing drugs with therapeutic potentials for COVID-19. The analysis was based on different rationales including anti-coronavirus activity, broad-spectrum antiviral activity and antiviral drugs with highly conserved viral target such as RNA dependent RNA polymerase (RDRP). We will constantly update these lists with new discoveries. 


## Data analysis results from previous coronavirus related drug discovery records

A collection of drug candidates with previously published positive coronavirus experimental results.

| Drug name                     | DrugBank ID                                      | Mechanism of action                                          | Experimental activity                                        | Methods                                               | Measurement | Value    | Unit |
| ----------------------------- | ------------------------------------------------ | ------------------------------------------------------------ | ------------------------------------------------------------ | ----------------------------------------------------- | ----------- | -------- | ---- |
| Remdesivir                    | [DB14761](https://www.drugbank.ca/drugs/DB14761) | Nucleobindin-1 (NUCB1) Inhibitors                            | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO | Viral replication assay                               | IC-50       | 1.00E-08 | M    |
| Emetine                       | [DB13393](https://www.drugbank.ca/drugs/DB13393) | Platelet-Derived Growth Factor (PDGF) Inhibitors;Signal Transduction Modulators;Angiogenesis Inhibitors | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO | Cytopathicity assay                                   | IC-50       | 1.50E-07 | M    |
| Nafamostat mesilate           | [DB12598](https://www.drugbank.ca/drugs/DB12598) | Tryptase Inhibitors                                          | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO | Vero cells (TMPRSS2-expressing) transfected with MERS | IC-50       | 1.00E-09 | M    |
| Alisporivir                   | [DB12139](https://www.drugbank.ca/drugs/DB12139) | P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Cyclophilin Inhibitors | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | RNA assay                                             | IC-50       | 8.00E-07 | M    |
| Niclosamide                   | [DB06803](https://www.drugbank.ca/drugs/DB06803) | Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO | Cytopathicity assay                                   | IC-50       | 1.00E-07 | M    |
| Rupintrivir                   | [DB05102](https://www.drugbank.ca/drugs/DB05102) | HRV 3C Protease Inhibitors                                   | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | Viral replication assay                               | IC-50       | 3.00E-07 | M    |
| Geldanamycin                  | [DB02424](https://www.drugbank.ca/drugs/DB02424) | Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO |                                                       | IC-50       | 9.10E-07 | M    |
| Sinefungin                    | [DB01910](https://www.drugbank.ca/drugs/DB01910) | Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators | Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO |                                                       | IC-50       | 3.83E-07 | M    |
| Mycophenolic acid sodium salt | [DB01024](https://www.drugbank.ca/drugs/DB01024) | Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors    | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO | Cytopathicity assay                                   | IC-50       | 1.70E-07 | M    |
| Mycophenolate mofetil         | [DB00688](https://www.drugbank.ca/drugs/DB00688) | Hydroxycarboxylic Acid Receptor 2 (HCAR2; NIACR1; GPR109A) Agonists;Signal Transduction Modulators;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | Viral replication assay                               | IC-50       | 2.30E-07 | M    |
| Chloroquine                   | [DB00608](https://www.drugbank.ca/drugs/DB00608) |                                                              | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO |                                                       | IC-50       | 8.00E-10 | M    |
| Gemcitabine hydrochloride     | [DB00441](https://www.drugbank.ca/drugs/DB00441) | Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | Cytopathicity assay                                   | IC-50       | 4.40E-07 | M    |
| Promazine                     | [DB00420](https://www.drugbank.ca/drugs/DB00420) | Signal Transduction Modulators;Dopamine Receptor Antagonists | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | Cytopathicity assay                                   | MIC         | 1.00E-07 | M    |
| Azithromycin                  | [DB00207](https://www.drugbank.ca/drugs/DB00207) | Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO | Luciferine/luciferase assay                           | IC-50       | 1.00E-07 | M    |
| cyclosporin                   | [DB00091](https://www.drugbank.ca/drugs/DB00091) | Cyclophilin Inhibitors;Mitochondrial Permeability Transition (MPT) Inhibitors | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO | RNA assay                                             | IC-50       | 8.00E-07 | M    |

## Broad-spectrum antiviral data analysis results

Based on in vitro viral infection assay results (EC50<=1uM) and clinical data (in vivo active) we have identified 51 molecules against at least 5 virus species and 10 molecules against at least 10 virus species. The details of the top candidates are shown below:

|  ï»¿Drug name  | Drug ID  | Number of virus speices  | Virus species list  | Discovered MOA  |
| ---- | --- | --- | --- | --- |
|  Tenofovir  | [DB14126](https://www.drugbank.ca/drugs/DB14126)  | 15  | FLUAV;HCV;HBV;HSV;HSV-2;HIV-1;HIV-2;ADV;DENV;RSV;CMV;VZV;Parainfluenza virus;Rhinovirus;Xenotropic murine leukemia virus-related virus  | Nucleotide reverse transcriptase inhibitor  |
|  Nitazoxanide  | [DB00507](https://www.drugbank.ca/drugs/DB00507)  | 13  | MERS-CoV;ZIKV;FLUAV;FLUBV;HBV;HCV;HIV-1;DENV;RSV;ADV;NoV;RuV;JEV  | Hemagglutinin inhibitor  |
|  Mycophenolic acid  | [DB01024](https://www.drugbank.ca/drugs/DB01024)  | 13  | MERS-CoV;CoV;ZIKV;DENV;HCV;FLUAV;FLUBV;WNV;RSV;BKV;Avian flu;Filovirus;Parainfluenza virus  | Dehydrogenase  |
|  Brincidofovir  | [DB12151](https://www.drugbank.ca/drugs/DB12151)  | 13  | EBOV;CMV;HSV;VZV;BKV;ADV;EBV;HTLV-1;HPV;HSV-1;HSV-6;VACV;JC polyomavirus  | DNA polymerase Inhibitor  |
|  Ribavirin  | [DB00811](https://www.drugbank.ca/drugs/DB00811)  | 11  | FLU;FLUAV;FLUBV;HCV;RSV;EV;HSV;HEV;LASV;Avian flu;Parainfluenza virus  | Inosine monophosphate dehydrogenase inhibitor; RNA-dependent RNA polymerase inhibitor  |
|    | [CID:5480370](https://pubchem.ncbi.nlm.nih.gov/compound/5480370)  | 11  | FLUAV;DENV;HBV;HCV;HSV;ADV;RSV;CMV;VZV;Rhinovirus;Parainfluenza virus  |   |
|  Remdesivir  | [DB14761](https://www.drugbank.ca/drugs/DB14761)  | 10  | CoV;SARS-CoV;MERS-CoV;2019nCoV;EBOV;ZIKV;MARV;HCV;RSV;Filovirus  | RNA polymerase inhibitor  |
|  Tilorone  | [DB09070](https://www.drugbank.ca/drugs/DB09070)  | 10  | MERS-CoV;EBOV;HBV;HCV;CHIKV;CMV;HAV;HSV-1;MARV;WNV   | Interferon inducers  |
|  Cidofovir  | [DB00369](https://www.drugbank.ca/drugs/DB00369)  | 10  | HPV;CMV;HSV;EBV;VZV;ADV;BKV;HSV-1;HSV-2;JC polyomavirus  | DNA polymerase Inhibitor  |
|    | [CID:71761402](https://pubchem.ncbi.nlm.nih.gov/compound/71761402)  | 10  | SARS-CoV;FLUAV;FLUBV;DENV;ADV;RSV;WNV;Filovirus;Rhinovirus;Parainfluenza virus  |   |



Top 51 list



| ID   | Drug name                                                    | Number of virus species | Virus speices list                                           | Discovered MOA                                               |
| ---- | ------------------------------------------------------------ | ----------------------- | ------------------------------------------------------------ | ------------------------------------------------------------ |
| 1    | Tenofovir                                                    | 15                      | Influenza A virus;Hepatitis C virus;Hepatitis B virus;Herpes simplex virus;Adenovirus;Dengue virus;Parainfluenza virus;Respiratory syncytial virus;Rhinovirus;Cytomegalovirus;Varicella zoster virus;Xenotropic murine leukemia virus-related virus;Human immunodeficiency virus 2;Human immunodeficiency virus 1;Herpes simplex virus 2 | Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors |
| 2    | Brincidofovir                                                | 13                      | Ebola virus;Cytomegalovirus;Herpes simplex virus;Varicella zoster virus;BK polyomavirus;Adenovirus;JC polyomavirus;Epstein Barr virus;T-lymphotropic virus type 1;Human papilloma virus (HPV);Herpes simplex virus 1;Vaccinia virus;Human herpesvirus 6 | DNA Polymerase Inhibitors                                    |
| 3    | Nitazoxanide                                                 | 13                      | Influenza A virus;Influenza B virus;Hepatitis B virus;Hepatitis C virus;Dengue virus;Respiratory syncytial virus;Adenovirus;Norovirus;Rubella virus;Human immunodeficiency virus 1;Japanese encephalitis virus;MERS-CoV;Zika virus | Signal Transduction Modulators;Viral Maturation Inhibitors;Pyruvate Synthase (Pyruvate-Ferredoxin Oxidoreductase; PFOR) (Protozoal) Inhibitors;Myc Proto-Oncogene Protein (c-Myc) Inhibitors;Hemagglutinin (HA) (Viral) Inhibitors;Protein Disulfide-Isomerase A3 (PDIA3) Inhibitors;Viral Fusion Inhibitors;Pyruvate Synthase (Pyruvate-Ferredoxin Oxidoreductase; PFOR) (Bacterial) Inhibitors |
| 4    | Mycophenolic acid                                            | 13                      | Avian influenza virus;Hepatitis C virus;Influenza B virus;Filovirus;Influenza A virus;MERS-CoV;Coronavirus;West Nile virus;Dengue virus;Zika virus;Respiratory syncytial virus;Parainfluenza virus;BK polyomavirus | Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors    |
| 5    | Tenofovir alafenamide fumarate                               | 11                      | Influenza A virus;Hepatitis C virus;Hepatitis B virus;Herpes simplex virus;Parainfluenza virus;Adenovirus;Dengue virus;Respiratory syncytial virus;Rhinovirus;Cytomegalovirus;Varicella zoster virus | Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors |
| 6    | Ribavirin                                                    | 11                      | Avian influenza virus;Influenza B virus;Hepatitis C virus;Influenza virus;Influenza A virus;Respiratory syncytial virus;Enterovirus;Parainfluenza virus;Herpes simplex virus;Hepatitis E virus;Lassa virus | Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Equilibrative Nucleoside Transporter ENT1 Inhibitors |
| 7    | [(2R,3R,4S,5S)-5-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxypyrrolidin-2-yl]methyl (2S)-2-amino-3-methylbutanoate | 10                      | Filovirus;SARS-CoV;Influenza A virus;Influenza B virus;Parainfluenza virus;Dengue virus;Adenovirus;Rhinovirus;Respiratory syncytial virus;West Nile virus | RNA Polymerase Inhibitors                                    |
| 8    | Remdesivir                                                   | 10                      | MERS-CoV;Filovirus;Ebola virus;Coronavirus;SARS-CoV;Marburg virus;Hepatitis C virus;Respiratory syncytial virus;Zika virus;2019nCoV | Nucleobindin-1 (NUCB1) Inhibitors                            |
| 9    | Tilorone hydrochloride                                       | 10                      | Chikungunya virus;Cytomegalovirus;Ebola virus;Hepatitis A virus;Hepatitis B virus;Hepatitis C virus;Herpes simplex virus 1;Marburg virus;MERS-CoV;West Nile virus | Signal Transduction Modulators;Interferon Inducers           |
| 10   | Cidofovir                                                    | 10                      | Cytomegalovirus;Herpes simplex virus;Epstein Barr virus;Varicella zoster virus;JC polyomavirus;Adenovirus;BK polyomavirus;Herpes simplex virus 1;Herpes simplex virus 2;Human papilloma virus (HPV) | DNA Polymerase Inhibitors                                    |
| 11   | PTC299                                                       | 9                       | Influenza A virus;Hepatitis C virus;Poliovirus;Parainfluenza virus;West Nile virus;Respiratory syncytial virus;Adenovirus;Herpes simplex virus;Dengue virus | Signal Transduction Modulators;Vascular Endothelial Growth Factor (VEGF) Inhibitors;Angiogenesis Inhibitors |
| 12   | (4-chlorophenyl) (1S)-6-chloro-1-[4-[(3S)-3,4-dihydroxybutoxy]phenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate | 8                       | Influenza A virus;Poliovirus;Adenovirus;Parainfluenza virus;West Nile virus;Respiratory syncytial virus;Herpes simplex virus;Dengue virus | VEGF Expression Inhibitors;Angiogenesis Inhibitors           |
| 13   | Favipiravir                                                  | 8                       | Influenza A virus;Influenza B virus;Influenza C virus;2019nCoV;Crimean-Congo hemorrhagic fever virus;Chikungunya virus;Ebola virus;Marburg virus | Viral Polymerase Inhibitors                                  |
| 14   | OSU-03012                                                    | 8                       | Filovirus;Influenza A virus;Marburg virus;Ebola virus;Hepatitis C virus;Zika virus;Herpes simplex virus;Dengue virus | Acetyl-Coenzyme A Synthetase (Fungal) Inhibitors;Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors;Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors;Serine/Threonine-Protein Kinase PKH2 (Fungal) Inhibitors;Heat Shock Protein 70 (Hsp70) Inhibitors;Apoptosis Inducers |
| 15   | valaciclovir                                                 | 7                       | Herpes simplex virus;Cytomegalovirus;Epstein Barr virus;Hepatitis B virus;Herpes simplex virus 1;Herpes simplex virus 2;Varicella zoster virus | DNA Polymerase Inhibitors; DNA Directed DNA Polymerase Inhibitors |
| 16   | Chloroquine                                                  | 7                       | Coronavirus;Dengue virus;Human immunodeficiency virus 1;Chikungunya virus;Ebola virus;Influenza A virus;Hepatitis C virus |                                                              |
| 17   | Ciclosporin                                                  | 7                       | Hepatitis C virus;Influenza B virus;Coronavirus;Hepatitis B virus;Influenza A virus;Human immunodeficiency virus 1;Cytomegalovirus | Cyclophilin D Inhibitors;Signal Transduction Modulators;Serine/Threonine-Protein Phosphatase 2B (PPP3CC; PP2Bgamma; Calcineurin) Inhibitors;INS Expression Inhibitors |
| 18   | Silvestrol                                                   | 7                       | Coronavirus;Hepatitis C virus;MERS-CoV;Ebola virus;Epstein Barr virus;Human papilloma virus (HPV);Rhinovirus | Eukaryotic Initiation Factor 4A (eIF4A) Inhibitors;Apoptosis Inducers |
| 19   | Sirolimus                                                    | 7                       | Cytomegalovirus;Hepatitis C virus;BK polyomavirus;Influenza A virus;Human immunodeficiency virus 1;Kaposi's sarcoma-associated herpesvirus;Rift Valley fever virus | CCR5 Expression Inhibitors;Signal Transduction Modulators;Proteasome Inhibitors;Drugs Targeting B-Lymphocyte Antigen CD19;Mammalian Target of Rapamycin (mTOR; FRAP1) Inhibitors |
| 20   | deferiprone extended-release                                 | 7                       | Cytomegalovirus;BK polyomavirus;Varicella zoster virus;JC polyomavirus;Herpes simplex virus;Adenovirus;Epstein Barr virus | Chelating Agents; Cytochrome P450 CYP4F2 Inhibitors; Iron Absorption Inhibitors; Lipoxygenase 5 Inhibitors |
| 21   | NITD-008                                                     | 6                       | Filovirus;Hepatitis C virus;Enterovirus;Dengue virus;Zika virus;West Nile virus | RNA-Directed RNA Polymerase (NS5) (Dengue Virus) Inhibitors  |
| 22   | Aciclovir                                                    | 6                       | Hepatitis B virus;Herpes simplex virus;Varicella zoster virus;Epstein Barr virus;Herpes simplex virus 1;Herpes simplex virus 2 | DNA Polymerase Inhibitors                                    |
| 23   | KIN-269                                                      | 6                       | Influenza A virus;Coronavirus;Influenza B virus;Respiratory syncytial virus;West Nile virus;Dengue virus | Interferon Regulatory Factor 3 (IRF-3) Activators            |
| 24   | (-)-Epigallocatechin gallate                                 | 6                       | Adenovirus;Hepatitis C virus;Cytomegalovirus;Herpes simplex virus;Influenza A virus;Zika virus | SGLT-1 Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;Immune Checkpoint Inhibitors;Viral Attachment Inhibitors;Aromatase Inhibitors;beta-Amyloid (Abeta) Aggregation Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Efflux Pump (Bacterial) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Fatty Acid Synthase (FAS) Inhibitors;Signal Transduction Modulators;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (DYRK1A) Inhibitors;Proteasome Inhibitors;Indoleamine 2,3-dioxygenase 1 (IDO1; IDO) Inhibitors;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors;AP-1 Transcription Factor Complex Inhibitors;Glycoprotein 120 (gp120) Inhibitors;PDGFR Family Inhibitors;beta-Secretase (BACE) Inhibitors;Prolyl Endopeptidase (prolyl oligopeptidase; POP) Inhibitors;Antioxidants;Telomerase Reverse Transcriptase (TERT) Inhibitors;Antiamyloidogenic Agents;Angiogenesis Inhibitors;Serine Protease NS3 (HCV) Inhibitors;Wnt Signaling Inhibitors |
| 25   | Sunitinib malate                                             | 6                       | Hepatitis C virus;Ebola virus;Respiratory syncytial virus;Dengue virus;Zika virus;West Nile virus | Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET; CDHF12; PTC) Inhibitors;VEGFR-3 (FLT4) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Signal Transduction Modulators;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2; Dardarin) Inhibitors;CSF1R (c-FMS) Inhibitors;Flt3 (FLK2/STK1) Inhibitors;VEGFR-1 (Flt-1) Inhibitors;Angiogenesis Inhibitors |
| 26   | Lamivudine                                                   | 6                       | Hepatitis B virus;Hepatitis C virus;Enterovirus;Epstein Barr virus;Human immunodeficiency virus 1;Human immunodeficiency virus 2 | DNA Polymerase Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors |
| 27   | Azithromycin                                                 | 6                       | Ebola virus;SARS-CoV;MERS-CoV;Respiratory syncytial virus;Influenza A virus;Human immunodeficiency virus 1 | Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors |
| 28   | NHC                                                          | 6                       | Hepatitis C virus;Avian influenza virus;SARS-CoV;Influenza B virus;Influenza A virus;Respiratory syncytial virus |                                                              |
| 29   | 3-Bromo-3-deazaneplanocin                                    | 6                       | Influenza A virus;Influenza B virus;Filovirus;Epstein Barr virus;Herpes simplex virus;Parainfluenza virus |                                                              |
| 30   | Ganciclovir                                                  | 6                       | Coronavirus;Herpes simplex virus;Cytomegalovirus;Varicella zoster virus;Epstein Barr virus;Adenovirus | DNA Polymerase Inhibitors                                    |
| 31   | Zidovudine                                                   | 6                       | Avian influenza virus;Xenotropic murine leukemia virus-related virus;Epstein Barr virus;Enterovirus;Herpes simplex virus;T-lymphotropic virus type 1 | P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors |
| 32   | ABI-1968                                                     | 6                       | Hepatitis B virus;Herpes simplex virus;Cytomegalovirus;BK polyomavirus;Human papilloma virus (HPV);JC polyomavirus |                                                              |
| 33   | aUY-11                                                       | 5                       | Influenza virus;Hepatitis C virus;Influenza A virus;Cytomegalovirus;Herpes simplex virus | Viral Fusion Inhibitors                                      |
| 34   | Geldanamycin                                                 | 5                       | SARS-CoV;Hepatitis C virus;Hepatitis B virus;Cytomegalovirus;Herpes simplex virus | Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors |
| 35   | ODE-(S)HPMPA                                                 | 5                       | Hepatitis C virus;Hepatitis B virus;Herpes simplex virus;Adenovirus;Cytomegalovirus |                                                              |
| 36   | HDP-PME-cPr-DAP                                              | 5                       | Hepatitis B virus;Epstein Barr virus;Cytomegalovirus;Varicella zoster virus;Herpes simplex virus |                                                              |
| 37   | Di-O-decanoylcurcumin                                        | 5                       | Influenza A virus;Influenza B virus;Herpes simplex virus;Respiratory syncytial virus;Parainfluenza virus |                                                              |
| 38   | [(2S,3S,5R)-3-(dimethylamino)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2S)-2-amino-3-phenylpropanoate | 5                       | Influenza A virus;Influenza B virus;Respiratory syncytial virus;Herpes simplex virus;Parainfluenza virus |                                                              |
| 39   | Erlotinib hydrochloride                                      | 5                       | Filovirus;Hepatitis C virus;Respiratory syncytial virus;Ebola virus;Dengue virus | Signal Transduction Modulators;EGFR (HER1; erbB1) Inhibitors |
| 40   | NITD-982                                                     | 5                       | Influenza A virus;Influenza B virus;Hepatitis C virus;Dengue virus;Respiratory syncytial virus | Dihydroorotate Dehydrogenase (DHODH) Inhibitors              |
| 41   | Di-O-tryptophanylphenylalaninecurcumin                       | 5                       | Influenza A virus;Influenza B virus;Respiratory syncytial virus;Herpes simplex virus;Parainfluenza virus |                                                              |
| 42   | Lycorine                                                     | 5                       | Coronavirus;Hepatitis C virus;SARS-CoV;Dengue virus;West Nile virus |                                                              |
| 43   | (2S,4R)-4-(1H-Benzimidazol-2-ylsulfanyl)-1-(9H-fluoren-2-ylmethyl)-N-(2-methoxyethyl)pyrrolidine-2-carboxamide | 5                       | Influenza B virus;Hepatitis C virus;Influenza A virus;Dengue virus;Respiratory syncytial virus |                                                              |
| 44   | Lobucavir                                                    | 5                       | Hepatitis B virus;Herpes simplex virus;Varicella zoster virus;Cytomegalovirus;Human immunodeficiency virus 1 | DNA Polymerase Inhibitors                                    |
| 45   | C4-Ethyl-O-gamma-folylcurcumin                               | 5                       | Influenza A virus;Influenza B virus;Respiratory syncytial virus;Herpes simplex virus;Parainfluenza virus |                                                              |
| 46   | Lopinavir                                                    | 5                       | Human immunodeficiency virus 1;Human immunodeficiency virus 2;MERS-CoV;2019nCoV;Zika virus | HIV Protease Inhibitors                                      |
| 47   | Gemcitabine hydrochloride                                    | 5                       | Influenza A virus;Coronavirus;Hepatitis C virus;Zika virus;Herpes simplex virus | Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists |
| 48   | 4-amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | 5                       | Filovirus;Ebola virus;Hepatitis C virus;Respiratory syncytial virus;Parainfluenza virus | RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors;RNA-Directed RNA Polymerase (Respiratory Syncytial Virus) Inhibitors |
| 49   | HPMPA-(S)                                                    | 5                       | Varicella zoster virus;Herpes simplex virus;Epstein Barr virus;Cytomegalovirus;Adenovirus |                                                              |
| 50   | Oseltamivir phosphate                                        | 5                       | Influenza A virus;Influenza virus;Avian influenza virus;Influenza B virus;Parainfluenza virus | Neuraminidase (Sialidase) (Influenza Virus) Inhibitors       |
| 51   | LDC-4297                                                     | 5                       | Influenza A virus;Cytomegalovirus;Herpes simplex virus;Varicella zoster virus;Adenovirus | Signal Transduction Modulators;Cyclin-Dependent Kinase 7 (CDK7) Inhibitors;Apoptosis Inducers |



## Data analysis results from previous other antiviral drug discovery records

A collection of drug candidates in pipelines or marketed for different antiviral indications. All candidates have at least completed Phase I studies. However, not all have in vitro anti-coronavirus or anti-2019nCoV evidence yet, further studies using 2019-nCoV specific assays are required to evaluate their anti-2019nCoV potential. 


### 1. Antiviral candidates selected from viral replication assay

| Drug name               | DrugBank ID                                      | Clinical Information                                         | Mechanism of action                                          | Experimental activity                                        | Method                  | Measurement | Value    | Unit |
| ----------------------- | ------------------------------------------------ | ------------------------------------------------------------ | ------------------------------------------------------------ | ------------------------------------------------------------ | ----------------------- | ----------- | -------- | ---- |
| Deferiprone             | [DB08826](https://www.drugbank.ca/drugs/DB08826) | 1. Phase 4 completed  for acute iron intoxication <br/>2. Phase 4 completed for Hepatic impairment <br/>3.  Phase 4 completed for impaired kidney function <br/>4. Phase 4 completed for  Beta-Thalassemia <br/>5. Phase 4 completed for hemosiderosis <br/>6. Phase 4  completed for Prolonged QT Interval <br/>7. Phase III completed for Parkinson's  disease; <br/>Marketed for iron toxicity | Chelating Agents;Cytochrome P450 CYP4F2 Inhibitors           | Infection, BK polyomavirus remission/reduction, IN VITRO     | Viral replication assay | IC-50       | 3.50E-09 | M    |
| Raltegravir potassium   | [DB06817](https://www.drugbank.ca/drugs/DB06817) | Phase 4 completed  for HIV <br/>Marketed for Anti-Retroviral HIV | HIV Integrase Inhibitors                                     | Infection, xenotropic murine leukemia virus-related virus remission/reduction, IN VITRO | Viral replication assay | IC-50       | 5.00E-9  | M    |
| Verdinexor              | [DB12207](https://www.drugbank.ca/drugs/DB12207) | Phase 1 completed  for basic science on health volunteers    | Exportin-1 (CRM1, XPO1) Receptor Antagonists;Signal Transduction Modulators | Infection, JC polyomavirus remission/reduction, IN VITRO     | Viral replication assay | IC-50       | 7.50E-09 | M    |
| Brincidofovir           | [DB12151](https://www.drugbank.ca/drugs/DB12151) | Phase 3 completed  for adenovirus infections                 | DNA Polymerase Inhibitors                                    | Infection, JC polyomavirus remission/reduction, IN VITRO     | Viral replication assay | IC-50       | 2.00E-8  | M    |
| Remdesivir              | [DB14761](https://www.drugbank.ca/drugs/DB14761) | 1. Phase III for  Ebola <br>2. Phase III for nCoV            | Nucleobindin-1 (NUCB1) Inhibitors                            | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO | Viral replication assay | IC-50       | 2.50E-8  | M    |
| Verdinexor              | [DB12207](https://www.drugbank.ca/drugs/DB12207) | Phase I completed  for basic science experiments on healthy volunteers | Exportin-1 (CRM1, XPO1) Receptor Antagonists;Signal Transduction Modulators | Infection, adenovirus remission/reduction, IN VITRO          | Viral replication assay | IC-50       | 3.00E-8  | M    |
| Cidofovir               | [DB00369](https://www.drugbank.ca/drugs/DB00369) | Phase 4 completed  for cytomegalovirus <br/>Marketed for CMV in AIDS patients | DNA Polymerase Inhibitors                                    | Infection, cytomegalovirus remission/reduction, IN VITRO     | Viral replication assay | IC-99       | 6.00E-8  | M    |
| Alvocidib hydrochloride | [DB03496](https://www.drugbank.ca/drugs/DB03496) | 1. Phase II  completed for sarcomas <br>2. Phase II completed for renal cancers; <br>3. Phase II  completed for melanoma <br>4. Phase II completed for other cancers including:  myeloma, carcinoma, esophageal, endometrial, leukaemia, etc. | Cyclin-Dependent Kinase 1 (CDK1) Inhibitors;Signal Transduction Modulators;Cyclin-Dependent Kinase 6 (CDK6) Inhibitors;CDK9/Cyclin T1 Inhibitors;Baculoviral IAP Repeat-Containing Protein 5 (BIRC5; Survivin) Inhibitors;Apoptosis Inducers;Cyclin-Dependent Kinase 7 (CDK7) Inhibitors;Cyclin-Dependent Kinase 2 (CDK2) Inhibitors;Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 Inhibitors;Cyclin-Dependent Kinase 4 (CDK4) Inhibitors;X-Chromosome-Linked Inhibitor of Apoptosis Protein (XIAP) Inhibitors;Apoptosis Regulator Bcl-2 Inhibitors | Infection, herpes virus remission/reduction, IN VITRO        | Viral replication assay | IC-50       | 1.00E-07 | M    |
| Ganciclovir             | [DB01004](https://www.drugbank.ca/drugs/DB01004) | 1. Phase 4 active  for viral pneumonia <br>2. Phase 4 completed for DNA virus infections <br>3. Phase 4  completed for CMV <br>4. Phase 4 completed for viral sepsis | DNA Polymerase Inhibitors                                    | Infection, herpes simplex virus remission/reduction, IN VITRO | Viral replication assay | IC-50       | 1.00E-8  | M    |

---

### 2. Top antiviral candidates with RDRP inhibition MOA selected from different assays

| Drug name      | DrugBank ID                                      | Mechanism of action                                          | Experimental activity                                        | Measurement | Value    | Unit |
| -------------- | ------------------------------------------------ | ------------------------------------------------------------ | ------------------------------------------------------------ | ----------- | -------- | ---- |
| Beclabuvir     | [DB12225](https://www.drugbank.ca/drugs/DB12225) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors         | Hepatitis C (HCV) remission/reduction, IN VITRO              | IC-50       | 3.00E-09 | M    |
| Remdesivir     | [DB14761](https://www.drugbank.ca/drugs/DB14761) | RNA-Dependent RNA Polymerase Inhibitor                       | Ebola virus disease remission/reduction, IN VITRO            | IC-50       | 1.00E-08 | M    |
| Valopicitabine | [DB13920](https://www.drugbank.ca/drugs/DB13920) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors         | Hepatitis C (HCV) remission/reduction, IN VITRO              | IC-50       | 9.00E-08 | M    |
| Mericitabine   | [DB12045](https://www.drugbank.ca/drugs/DB12045) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors         | Hepatitis C (HCV) remission/reduction, IN VITRO              | IC-50       | 1.30E-07 | M    |
| Lumicitabine   | [DB14808](https://www.drugbank.ca/drugs/DB14808) | RNA-Dependent RNA Polymerase (Respiratory Syncytial Virus) Inhibitors | Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO | IC-50       | 2.60E-07 | M    |
| Sofosbuvir     | [DB08934](https://www.drugbank.ca/drugs/DB08934) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors         | Infection, dengue virus remission/reduction, IN VITRO        | IC-90       | 4.00E-07 | M    |
| Adafosbuvir    | [DB14906](https://www.drugbank.ca/drugs/DB14906) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors         | Infection, dengue virus remission/reduction, IN VITRO        | IC-50       | 1.10E-06 | M    |
| Balapiravir hydrochloride | [DB12283](https://www.drugbank.ca/drugs/DB12283) | RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors          | Infection, dengue virus remission/reduction, IN VITRO        | IC-50     |1.9E-06  | M    |
| Galidesivir | [DB11676](https://www.drugbank.ca/drugs/DB11676) |RNA-Dependent RNA Polymerase Inhibitors|  Infection, Zika virus remission/reduction, IN VITRO                             | IC-50     | 2.96E-06 | M    |
| Favipiravir   | [DB12466](https://www.drugbank.ca/drugs/DB12466) |RNA-Dependent RNA Polymerase Inhibitors| Infection, rabies virus remission/reduction, IN VITRO                             | MIC       |  4.0E-06   | M    |


*Compounds selected based on best IC-50 measurement from respective assays.

